SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001683168-23-006837
Filing Date
2023-09-29
Accepted
2023-09-29 16:30:50
Documents
5
Effectiveness Date
2023-09-29

Document Format Files

Seq Description Document Type Size
1 FORM S-8 phio_s8.htm S-8 45360
2 OPINION OF HOGAN LOVELLS US LLP. phio_ex0501.htm EX-5.1 7103
3 CONSENT phio_ex2301.htm EX-23.1 2173
4 FILING FEE TABLE phio_ex107.htm EX-FILING FEES 25059
5 GRAPHIC image_003.jpg GRAPHIC 2231
  Complete submission text file 0001683168-23-006837.txt   84029
Mailing Address 257 SIMARANO DRIVE SUITE 101 MARLBOROUGH MA 01752
Business Address 257 SIMARANO DRIVE SUITE 101 MARLBOROUGH MA 01752 (508) 767-3861
Phio Pharmaceuticals Corp. (Filer) CIK: 0001533040 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-274787 | Film No.: 231296168
SIC: 2834 Pharmaceutical Preparations